Latest Anticoagulants Stories
The results of a recently-concluded study purport to show that Xarelto (rivaroxaban) is as safe as warfarin for patients atrial fibrillation patients awaiting elective cardioversion, even though
BARCELONA, Spain, September 2, 2014 /PRNewswire/ -- -- GARFIELD-AF Registry presentations at ESC CONGRESS 2014 provide insight into treatment and outcomes of patients
Results presented during ESC Congress 2014 Clinical Trial Update Hot Line session BARCELONA, Spain, Sept.
X-VeRT Study Results Presented as a Hot Line Session at the ESC Congress 2014 and Published in European Heart Journal BARCELONA, Spain, Sept.
A study released August 1 highlights the challenges related to managing anticoagulant–associated intracerebral hemorrhage (AAICH). Washington, D.C.
Kristine Kraft, partner at Schlichter, Bogard & Denton, LLP, reports on the findings of a new study published in the Journal of Neurosurgery regarding the increased difficulties of stopping
-- Results from X-VeRT, the first prospective exploratory study of a Factor Xa inhibitor in patients with atrial fibrillation undergoing cardioversion, will be presented during an ESC Congress 2014
New York Drug Liability Lawyer discusses the dangers of the anticoagulant drug Xarelto and the potential risks involved when taking Xarelto. (PRWEB) August 12,
The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news.
Court Documents Indicate a Number of Xarelto Bleeding Lawsuits Have Been Filed In U.S.
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.